ITGR Integer Holdings Corp — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$96.31

Period return

+10.77 (+12.59%)

Volume

223.4K

2026-07-21O $95.42 H $96.47 L $94.9 C $96.31MA5 $96.6MA20 $93.85MA60 $90.63MA120 $88.32

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 30.Highin 9 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 29.LowHOLD2 months ago
Citigroup: Neutral
US analyst rating / recommendation change.
2026. 05. 13.MediumBUY2 months ago
Oppenheimer: Outperform
US analyst rating / recommendation change.
2026. 05. 02.LowHOLD3 months ago
Citigroup: Neutral
US analyst rating / recommendation change.
2026. 05. 02.LowBUY3 months ago
Piper Sandler: Overweight
US analyst rating / recommendation change.
2026. 02. 21.LowHOLD5 months ago
Citigroup: Neutral
US analyst rating / recommendation change.
2026. 02. 21.LowHOLD5 months ago
Wells Fargo: Equal-Weight
US analyst rating / recommendation change.
2026. 02. 21.MediumBUY5 months ago
Benchmark: Buy
US analyst rating / recommendation change.
2026. 02. 20.LowBUY5 months ago
Truist Securities: Buy
US analyst rating / recommendation change.
2025. 12. 18.LowBUY7 months ago
Truist Securities: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $97.56 · 9 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 07. 30.	After market close (AMC)	$1.38	—	—	$450.5M	—	Scheduled
FY2026 Q1	2025. 03. 28.	Time TBD	—	$-0.66	—	—	$437.39M	Reported
FY2025 Q3	2024. 09. 27.	Time TBD	—	$2.46	—	—	$1.27B	Reported
FY2025 Q2	2024. 06. 28.	Time TBD	—	$1.47	—	—	$835.68M	Reported

Integer Holdings Corp

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 29.	Citigroup	—	Maintain	Neutral → Neutral	—	Citigroup: Neutral
2026. 05. 13.	Oppenheimer	—	Upgrade	Perform → Outperform	—	Oppenheimer: Perform → Outperform
2026. 05. 02.	Citigroup	—	Maintain	Neutral → Neutral	—	Citigroup: Neutral
2026. 05. 02.	Piper Sandler	—	Maintain	Overweight → Overweight	—	Piper Sandler: Overweight
2026. 02. 21.	Citigroup	—	Maintain	Neutral → Neutral	—	Citigroup: Neutral
2026. 02. 21.	Wells Fargo	—	Maintain	Equal-Weight → Equal-Weight	—	Wells Fargo: Equal-Weight